Implementation of cervical cancer prevention services for HIV-infected women in Zambia: Measuring program effectiveness

HIV Therapy

Volumn 4, Issue 6, 2010, Pages 713-722

  Parham, Groesbeck P ^a,b,c   Mwanahamuntu, Mulindi H ^b,c   Sahasrabuddhe, Vikrant V ^d,e   Westfall, Andrew O ^b   King, Kristin E ^f   Chibwesha, Carla ^a,b   Pfaendler, Krista S ^g   Mkumba, Gracilia ^b,c   Mudenda, Victor ^c   Kapambwe, Sharon ^b,c   Vermund, Sten H ^d   Hicks, Michael L ^h   Stringer, Jeffrey S A ^a,b   Chi, Benjamin H ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^c UNIVERSITY TEACHING HOSPITAL   (Zambia)

^d VANDERBILT UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g UNIVERSITY OF CINCINNATI   (United States)

^h Michigan Cancer Institute   (United States)

Author keywords

cervical cancer; HIV AIDS; program effectiveness; screening; Zambia

Indexed keywords

ACETIC ACID; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BENIGN TUMOR; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CANCER THERAPY; CONTROLLED STUDY; CRYOTHERAPY; DATA ANALYSIS; DIGITAL CERVICOGRAPHY; DIGITAL IMAGING; FEMALE; HEALTH PROGRAM; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INVASIVE CERVICAL CANCER; MAJOR CLINICAL STUDY; NURSE; OUTCOME ASSESSMENT; PUBLIC HEALTH SERVICE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; ZAMBIA;

EID: 78650569025     PISSN: 17584310     EISSN: None     Source Type: Journal    
DOI: 10.2217/hiv.10.52     Document Type: Article

References (42)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J. Clin. 55(2), 74-108 (2005).
2. Gakidou E, Nordhagen S, Obermeyer Z: Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 5(6), e132 (2008).
3. Sankaranarayanan R, Esmy PO, Rajkumar R et al.: Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 370(9585), 398-406 (2007).
4. Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC Jr. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 294(17), 2173-2181 (2005).
5. Blumenthal PD, Gaffikin L, Deganus S, Lewis R, Emerson M, Adadevoh S: Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am. J. Obstet. Gynecol. 196(4), 407 e401-408, discussion 407 e408-409 (2007).
6. Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K: Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet 361(9360), 814-820 (2003).
7. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH et al.: Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol. Oncol. 103(3), 1017-1022 (2006).
8. Denny L, Boa R, Williamson AL et al.: Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet. Gynecol. 111(6), 1380-1387 (2008).
9. Clifford GM, Polesel J, Rickenbach M et al.: Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J. Natl Cancer Inst. 97(6), 425-432 (2005).
10. Stringer JS, Zulu I, Levy J et al.: Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296(7), 782-793 (2006).
11. Mermin J, Were W, Ekwaru JP et al.: Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet 371(9614), 752-759 (2008). (Pubitemid 351297773)
12. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH et al.: Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br. J. Cancer. 96(9), 1480-1483 (2007).
13. Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS et al.: Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS 23(6), N1-N5 (2009).
14. Parham GP, Mwanahamuntu MH, Pfaendler KS et al.: eC3 - a modern telecommunications matrix for cervical cancer prevention in Zambia. J. Low. Genit. Tract Dis. 14(3), 167-173 (2010).
15. Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP: Management of cryotherapyin-eligible women in a "screen-and- treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol. Oncol. 110(3), 402-407 (2008).
16. Bomfim-Hyppolito S, Franco ES, Franco RG, de Albuquerque CM, Nunes GC: Cervicography as an adjunctive test to visual inspection with acetic acid in cervical cancer detection screening. Int. J. Gynaecol. Obstet. 92(1), 58-63 (2006).
17. Cremer ML, Peralta EI, Dheming SG et al.: Digital assessment of the reproductive tract versus colposcopy for directing biopsies in women with abnormal Pap smears. J. Low Genit. Tract Dis. 14(1), 5-10 (2010).
18. Cremer M, Jamshidi RM, Muderspach L, Tsao-Wei D, Felix JC, Blumenthal PD: Digital camera assessment for detection of cervical intraepithelial neoplasia in rural El Salvador. Int. J. Gynaecol. Obstet. 91(1), 42-46 (2005).
19. Massad LS, Evans CT, Minkoff H et al.: Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus. Obstet. Gynecol. 104(5 Pt 1), 1077-1085 (2004).
20. Nappi L, Carriero C, Bettocchi S, Herrero J, Vimercati A, Putignano G: Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women. Eur. J. Obstet. Gynecol. Reprod. Biol. 121(2), 226-232 (2005).
21. Delmas MC, Larsen C, van Benthem B et al.: Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women. AIDS 14(12), 1775-1784 (2000).
22. Robinson WR, Luck MB, Kendall MA, Darragh TM: The predictive value of cytologic testing in women with the human immunodeficiency virus who have low-grade squamous cervical lesions: a substudy of a randomized, phase III chemoprevention trial. Am. J. Obstet. Gynecol. 188(4), 896-900 (2003).
23. Robinson WR, Hamilton CA, Michaels SH, Kissinger P: Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am. J. Obstet. Gynecol. 184(4), 538-543 (2001).
24. Stein MD, Cunningham WE, Nakazono T et al.: Screening for cervical cancer in HIV-infected women receiving care in the United States. J. Acquir. Immune Defic. Syndr. 27(5), 463-466 (2001). (Pubitemid 32801075)
25. Maiman M, Fruchter RG, Guy L, Cuthill S, Levine P, Serur E: Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 71(2), 402-406 (1993).
26. Moodley M: Radical hysterectomy for cervical cancer amongst women infected with the human immunodeficiency virus. Int. J. Gynecol. Cancer 17(6), 1264-1265 (2007).
27. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer (2010) (Epub ahead of print).
28. Hallett TB, Stover J, Mishra V, Ghys PD, Gregson S, Boerma T: Estimates of HIV incidence from household-based prevalence surveys. AIDS 24(1), 147-152 (2010).
29. Stringer EM, Chintu NT, Levy JW et al.: Declining HIV prevalence among young pregnant women in Lusaka, Zambia. Bull World Health Organ. 86(9), 697-702 (2008).
30. Akinwuntan AL, Adesina OA, Okolo CA et al.: Correlation of cervical cytology and visual inspection with acetic acid in HIV-positive women. J. Obstet. Gynaecol. 28(6), 638-641 (2008).
31. Singh DK, Anastos K, Hoover DR et al.: Human papillomavirus infection and cervical cytology in HIV-infected and HIVuninfected Rwandan women. J. Infect. Dis. 199(12), 1851-1861 (2009).
32. Sahasrabuddhe VV, Bhosale RA, Joshi SN et al.: Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One. 5(1), e8634 (2010).
33. Chirwa S, Mwanahamuntu M, Kapambwe S et al.: Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob. Health Promot. 17(2 Suppl.), 47-50 (2010).
34. Louie KS, de Sanjose S, Mayaud P: Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop. Med. Int. Health. 14(10), 1287-1302 (2009).
35. Strickler HD, Burk RD, Fazzari M et al.: Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J. Natl Cancer Inst. 97(8), 577-586 (2005).
36. Heard I, Tassie JM, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G: Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Obstet. Gynecol. 96(3), 403-409 (2000).
37. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD: Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 12(12), 1459-1464 (1998). (Pubitemid 28369645)
38. Richart RM. Screening. The next century. Cancer. 76(10 Suppl.), 1919-1927 (1995).
39. Massad LS, Seaberg EC, Watts DH et al.: Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer. 115(3), 524-530 (2009).
40. Russomano F, Reis A, Camargo MJ, Grinsztejn B, Tristao MA: Recurrence of cervical intraepithelial neoplasia grades 2 or 3 in HIV-infected women treated by large loop excision of the transformation zone (LLETZ). Sao Paulo Med. J. 126(1), 17-22 (2008).
41. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM: Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-ana lysis. Lancet 370(9581), 59-67 (2007).
42. Denny CC, Emanuel EJ. US health aid beyond PEPFAR: the Mother & Child Campaign. JAMA 300(17), 2048-2051 (2008).